Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis
โ Scribed by CHIH-HSING HUNG; YI-MING HUA; WAN-TING HSU; YUAN-SHENG LAI; KUENDER D YANG; YUH-JYH JONG; YU-TE CHU
- Book ID
- 108971294
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 77 KB
- Volume
- 49
- Category
- Article
- ISSN
- 1328-8067
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Nitric oxide (NO) is produced by various cell types in the human respiratory tract. Endogenously produced nitric oxide is detectable in the exhaled air of healthy individuals. Exhaled NO has been shown to be increased in airway inflammation, most probably due to cytokine-mediated activation of NO sy
Exhaled nitric oxide (ENO) is a surrogate marker of airway inflammation in asthma. In 12 children aged 6-11 years with mild to moderate persistent asthma, ENO concentrations were measured before and after 4 weeks of treatment with montelukast sodium, a leukotriene receptor antagonist, and 2 weeks af